Moleculin Biotech
MBRX
MBRX
20 hedge funds and large institutions have $790K invested in Moleculin Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66.8K | |
| 2 | +$21.7K | |
| 3 | +$12.4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.39K |
| 5 |
Renaissance Technologies
New York
|
+$1.21K |
Top Sellers
| 1 | -$98.1K | |
| 2 | -$1.33K | |
| 3 | -$242 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$121 |
| 5 |
Morgan Stanley
New York
|
-$61 |